Karyopharm Therapeutics | KPTI - Валовая прибыль





Валовая прибыль Изменить Дата
AbbVie USD 14.39B 1.85B 2026-06
Abbott USD 6.65B 787M 2026-06
Amgen USD 5.87B 1.02B 2026-03
AstraZeneca USD 12.86B 251M 2026-06
BioCryst Pharmaceuticals USD 214.41M 61.36M 2026-06
Bristol-Myers Squibb USD 9.26B 1.19B 2026-06
Eli Lilly USD 16.22B 301.7M 2026-03
Enanta Pharmaceuticals -22.29M 23.75M 2024-12
GlaxoSmithKline GBP 6.51B 757M 2026-06
Incyte USD 1.57B 400.89M 2026-06
J&J USD 18.55B 1.31B 2026-06
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
MacroGenics USD 11.24M 19.87M 2026-03
Merck USD 12.09B 1.24B 2026-03
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Novartis USD 11.24B 1.18B 2026-06
Novartis USD 10.07B 758M 2026-03
Pfizer USD -248M 11.29B 2026-06
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Takeda JPY 813.22B 124.39B 2026-06
Tectonic Therapeutic USD 0 0 2025-03
TG Therapeutics USD 199.14M 27.73M 2026-06
Ultragenyx Pharmaceutical USD 180M 74M 2026-06
Xencor USD 51.22M 46.7M 2026-06